Streetbeat News

Acquisitions Mergers

VSTO

Vista Outdoor has rejected an unsolicited indication of interest from MNC Capital and reaffirmed its recommendation for the CSG transaction.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 11:53 am

VSTO

Vista Outdoor Inc. rejected a $2 billion takeover offer from MNC Capital, favoring a separate deal with Czechoslovak Group for its ammunition products business. MNC's offer was deemed undervalued and lacked committed financing. Vista will rebrand as Revelyst post-transaction, focusing on sports and outdoor equipment.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 11:45 am

BITF

RIOT

Riot Platforms is pursuing a takeover of rival Bitcoin miner Bitfarms, according to sources familiar with the matter.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 11:44 am

GROY

Gold Royalty shares are trading lower after the company announced a binding agreement to acquire a copper stream on the Vares Silver Project. Additionally, the company has entered into a $300 million bought deal financing agreement with National Bank Financial and BMO Capital Markets.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 11:43 am

TDS

TMUS

USM

UScellular and TDS have agreed to sell their wireless operations and select spectrum assets to T-Mobile for $4.4 billion. This transaction is expected to significantly impact the involved companies' stock prices in the short term.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 11:34 am

TDG

TransDigm Group Incorporated (TDG) has acquired Raptor Scientific for $655 million. This acquisition is expected to enhance TransDigm's product offerings and market position.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 11:32 am

JNJ

Johnson & Johnson is set to acquire Numab Therapeutics' subsidiary for global rights to NM26, a treatment for atopic dermatitis, for approximately $1.25 billion in cash.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 11:32 am

AY

Atlantica Sustainable Infrastructure shares are trading lower following the announcement of a definitive agreement to be acquired by Energy Capital Partners.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 11:32 am

CALT

Calliditas Therapeutics shares are trading higher following the company's board recommendation to accept Asahi Kasei's tender offer.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 11:29 am

AGIO

RPRX

Royalty Pharma has acquired an interest in Agios Pharmaceuticals' royalty on Servier's Vorasidenib for $905 million in upfront cash, contingent upon FDA approval of Vorasidenib.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 11:17 am